Aclaris Therapeutics, Inc.

DIMENSIONAL FUND ADVISORS LP ACRS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

270,850

Value ($000)

815

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	815	0.0%	270,850	12/31/2025
2025 Q3	11/12/2025	312	0.0%	164,244	9/30/2025
2025 Q2	8/12/2025	295	0.0%	207,273	6/30/2025
2025 Q1	5/13/2025	543	0.0%	354,849	3/31/2025
2024 Q4	2/13/2025	594	0.0%	239,595	12/31/2024
2024 Q3	11/7/2024	88	0.0%	76,810	9/30/2024
2024 Q2	8/9/2024	84	0.0%	76,759	6/30/2024
2024 Q1	5/10/2024	110	0.0%	89,061	3/31/2024
2023 Q4	2/7/2024	197	0.0%	187,553	12/31/2023
2023 Q3	11/9/2023	1,793	0.0%	261,733	9/30/2023
2023 Q2	8/9/2023	1,042	0.0%	100,457	6/30/2023
2023 Q1	5/12/2023	1,116	0.0%	137,923	3/31/2023
2022 Q4	2/9/2023	756	0.0%	48,017	12/31/2022
2022 Q3	11/10/2022	756	0.0%	48,017	9/30/2022
2021 Q3	11/12/2021	336	0.0%	18,640	9/30/2021
2021 Q2	8/12/2021	327	0.0%	18,640	6/30/2021
2021 Q1	5/14/2021	470	0.0%	18,640	3/31/2021
2020 Q4	3/8/2021	121	0.0%	18,640	12/31/2020
2020 Q3	11/12/2020	48	0.0%	18,632	9/30/2020
2020 Q2	8/13/2020	18	0.0%	11,413	6/30/2020
2020 Q1	5/14/2020	12	0.0%	11,413	3/31/2020
2019 Q4	2/14/2020	22	0.0%	11,413	12/31/2019